Paper374277
[Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
Federspil P and 5 others. Infection, 1979. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin]. Papers, record 374277. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/374277
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Hearing | Major topic |
| Kanamycin | Major topic |
| Kidney | Major topic |
| Vestibule, Labyrinth | Major topic |
| Adult | |
| Aged | |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors | |
| Urinary Tract Infections |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 868906 | Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. | Am J Med | 1977 | https://conductscience.org/library/papers/868906 | PubMed |
| 2 | 993623 | Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results. | J Infect Dis | 1976 | https://conductscience.org/library/papers/993623 | PubMed |
| 3 | 825585 | In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825585 | PubMed |
| 4 | 1101761 | Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. | Ann Intern Med | 1975 | https://conductscience.org/library/papers/1101761 | PubMed |
| 5 | 938024 | Ototoxicity of amikacin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/938024 | PubMed |
| 6 | 972282 | Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin. | J Infect Dis | 1976 | https://conductscience.org/library/papers/972282 | PubMed |
| 7 | 825591 | Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825591 | PubMed |
| 8 | 4462458 | Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4462458 | PubMed |
| 9 | 825588 | Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825588 | PubMed |
| 10 | 868900 | Mechanisms of resistance to aminoglycosides. | Am J Med | 1977 | https://conductscience.org/library/papers/868900 | PubMed |
| 11 | 5596140 | Round table: optimal duration of antibiotic therapy in severe bacterial infections. | Antimicrob Agents Chemother (Bethesda) | 1967 | https://conductscience.org/library/papers/5596140 | PubMed |
| 12 | 868909 | Amikacin therapy of gram-negative bacteremia. | Am J Med | 1977 | https://conductscience.org/library/papers/868909 | PubMed |
| 13 | 1200524 | Amikacin therapy for serious gram-negative bacillary infections. | Ann Intern Med | 1975 | https://conductscience.org/library/papers/1200524 | PubMed |
| 14 | 1017884 | [Ototoxicity of the aminoglycoside antibiotics (author's transl)]. | Infection | 1976 | https://conductscience.org/library/papers/1017884 | PubMed |
| 15 | 825589 | Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825589 | PubMed |
| 16 | 868907 | Comparison of amikacin and gentamicin in the treatment of urinary tract infections. | Am J Med | 1977 | https://conductscience.org/library/papers/868907 | PubMed |
| 17 | 62814 | Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates. | J Infect Dis | 1976 | https://conductscience.org/library/papers/62814 | PubMed |
| 18 | 868908 | Amikacin therapy for gram-negative septicemia. | Am J Med | 1977 | https://conductscience.org/library/papers/868908 | PubMed |
| 19 | 586099 | Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail. | Am J Med | 1977 | https://conductscience.org/library/papers/586099 | PubMed |
| 20 | 5494465 | [Clinical ototoxicity of gentamycin and its reversibility]. | Arch Klin Exp Ohren Nasen Kehlkopfheilkd | 1970 | https://conductscience.org/library/papers/5494465 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/374277
GET https://conductscience.org/api/papers/v1/374277/references?page=2